These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 11360668

  • 1. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats.
    Pan GY, Liu XD, Liu GQ.
    Acta Pharmacol Sin; 2000 Jul; 21(7):613-6. PubMed ID: 11360668
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR, Voorhies RM, Hiesiger EM, Sher PB, Basler GA, Lipschutz LE.
    Cancer Res; 1988 Feb 01; 48(3):694-701. PubMed ID: 3335031
    [Abstract] [Full Text] [Related]

  • 3. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain.
    Erdlenbruch B, Schinkhof C, Kugler W, Heinemann DE, Herms J, Eibl H, Lakomek M.
    Br J Pharmacol; 2003 Jun 01; 139(4):685-94. PubMed ID: 12812991
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E, Gomori JM, Schwartz A, Lossos A, Bokstein F, Siegal T.
    Clin Pharmacol Ther; 2000 Jun 01; 67(6):631-41. PubMed ID: 10872645
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.
    Neuwelt EA, Hill SA, Frenkel EP, Diehl JT, Maravilla KR, Vu LH, Clark WK, Rapoport SI, Barnett PA, Lewis SE, Ehle AL, Beyer CW.
    Cancer Treat Rep; 1981 Jun 01; 65 Suppl 2():39-43. PubMed ID: 6809316
    [Abstract] [Full Text] [Related]

  • 8. [ACNU delivery to malignant glioma tissue by osmotic blood brain barrier modification with intracarotid infusion of hyperosmoral mannitol].
    Miyagami M, Kagawa Y, Tsubokawa T.
    No Shinkei Geka; 1985 Sep 01; 13(9):955-63. PubMed ID: 2999632
    [Abstract] [Full Text] [Related]

  • 9. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
    Kaya M, Gulturk S, Elmas I, Kalayci R, Arican N, Kocyildiz ZC, Kucuk M, Yorulmaz H, Sivas A.
    Life Sci; 2004 Nov 26; 76(2):201-12. PubMed ID: 15519365
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synergistic effect of cold mannitol and Na(+)/Ca(2+) exchange blocker on blood-brain barrier opening.
    Ikeda M, Bhattacharjee AK, Kondoh T, Nagashima T, Tamaki N.
    Biochem Biophys Res Commun; 2002 Mar 01; 291(3):669-74. PubMed ID: 11855842
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of CNS penetration of methotrexate by hyperosmolar intracarotid mannitol or carcinomatous meningitis.
    Hasegawa H, Allen JC, Mehta BM, Shapiro WR, Posner JB.
    Neurology; 1979 Sep 01; 29(9 Pt 1):1280-6. PubMed ID: 573408
    [Abstract] [Full Text] [Related]

  • 16. Osmotic opening of the blood-brain barrier to methotrexate in the rat.
    Ohno K, Fredericks WR, Rapoport SI.
    Surg Neurol; 1979 Oct 01; 12(4):323-8. PubMed ID: 524251
    [Abstract] [Full Text] [Related]

  • 17. Modification of the blood-brain barrier permeability following intracarotid infusion of vinorelbine.
    Mouchard-Delmas C, Gourdier B, Vistelle R, Wiczewski M.
    Anticancer Res; 1995 Oct 01; 15(6B):2593-6. PubMed ID: 8669830
    [Abstract] [Full Text] [Related]

  • 18. Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin.
    Brown RC, Egleton RD, Davis TP.
    Brain Res; 2004 Jul 16; 1014(1-2):221-7. PubMed ID: 15213006
    [Abstract] [Full Text] [Related]

  • 19. Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.
    Spigelman MK, Zappulla RA, Strauchen JA, Feuer EJ, Johnson J, Goldsmith SJ, Malis LI, Holland JF.
    Cancer Res; 1986 Mar 16; 46(3):1453-7. PubMed ID: 3510725
    [Abstract] [Full Text] [Related]

  • 20. Increased blood-brain permeability with hyperosmolar mannitol increases cerebral O2 consumption and O2 supply/consumption heterogeneity.
    Chi OZ, Wei HM, Lu X, Weiss HR.
    J Cereb Blood Flow Metab; 1996 Mar 16; 16(2):327-33. PubMed ID: 8594066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.